Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology

Published: Feb 09, 2006

Pegasus/Heartview LLC (OTC: PGUZ) today announced that it has signed a sales agreement to market and distribute its HeartVueâ„¢ 6C System in China and southern Asia through the Pegasus PharmGroup and its marketing subsidiary, Pegasus Lifecare Inc.

Back to news